VCN Biosciences SL is a privately-owned company focused in the development of new therapeutic approaches for tumors that lack effective treatment. The company uses an oncolytic adenovirus technology platform to design highly selective and efficient agents that replicate and self-amplify exclusively in tumor cells. The selectivity of VCN oncolytic adenoviruses allows their systemic administration, which is especially relevant for the treatment of disseminated cancer. Contrary to chemotherapy, the ability of oncolytic virus to self-amplify in tumor cells results in an effective dose increase with time. These properties highlight VCN candidates as promising alternatives for the treatment of refractory tumors such as pancreatic adenocarcinomas, which is the current tumor target for VCN-01
View Top Employees from VCN Biosciences SLWebsite | http://www.vcnbiosciences.com |
Revenue | $5.5 million |
Employees | 11 (10 on RocketReach) |
Founded | 2009 |
Address | 152 Ave De La Generalitat, Sant Cugat del Valles, Catalonia 08174, ES |
Phone | +34 609 43 23 75 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Biotechnology, Business Services General, Drug Discovery, Business Services, Science and Engineering |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular VCN Biosciences SL employee's phone or email?
The VCN Biosciences SL annual revenue was $5.5 million in 2024.
10 people are employed at VCN Biosciences SL.
VCN Biosciences SL is based in Sant Cugat del Valles, Catalonia.
The NAICS codes for VCN Biosciences SL are [541714, 54171, 54, 541, 5417].
The SIC codes for VCN Biosciences SL are [873, 87].